Treatment options of alpha<unk> -antitrypsin deficiency currently being studied include recombination and inhaled forms of Alpha<unk> -antitrypsin. Other experimental<unk>  are aimed at the prevention of polymer formation in the liver. Gene therapy to deliver recombinant adeno-associated virus carrying the human AAT gene is also being investigated as a alternate treatment approach.
Alpha 1-antitrypsin deficiency future or investigational therapies
Alpha 1-antitrypsin deficiency primary prevention
Alpha 1-antitrypsin deficiency secondary prevention
Idiopathic pulmonary fibrosis primary prevention
Cystic fibrosis future or investigational therapies
Chronic bronchitis primary prevention
Hypersensitivity pneumonitis medical therapy
Asthma primary prevention